Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FY1P0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,352
Award facts
- Contract value 100% obligated
- $12,351.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,351.78 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on October 29, 2025, with completion scheduled for October 30, 2025. This competitive award, made without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical supplies to be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant role in federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering diverse pharmaceutical commodities including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Dupixent, a specialty pharmaceutical product, reflects the vendor's continued capability to fulfill specific medical supply requirements through the DLA's competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB26FY1P0?
SPE2DB26FY1P0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FY1P0 worth?
The government has obligated $12,352 on SPE2DB26FY1P0.
Is contract SPE2DB26FY1P0 an order under another contract?
Yes. SPE2DB26FY1P0 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1P0 competed?
The extent of competition for SPE2DB26FY1P0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award